Skip to Content

WATSON 3159 (Ursodiol 300 mg)

Pill with imprint WATSON 3159 is White, Capsule-shape and has been identified as Ursodiol 300 mg. It is supplied by Watson Pharmaceuticals.

Ursodiol is used in the treatment of primary biliary cholangitis ; nonalcoholic fatty liver disease; gallbladder disease and belongs to the drug class gallstone solubilizing agents. There is no proven risk in humans during pregnancy. Ursodiol 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 3159

Ursodiol 300 mg WATSON 3159 Front
Ursodiol 300 mg WATSON 3159 Back
Ursodiol 300 mg WATSON 3159
Ursodiol 300 mg WATSON 3159

Ursodiol

Imprint:
WATSON 3159
Strength:
300 mg
Color:
White
Size:
22.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Gallstone solubilizing agents
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
Inactive Ingredients:
silicon dioxide colloidal
ferric oxide
gelatin
magnesium stearate
corn starch
ferrosoferric oxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
68084-0213 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide